Delivery Order SPE2DB22D3011-SPE2DB24FP9GF
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $2.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,874.29 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in 60-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of JANUMET XR 100-1,000 MG tablets, with a ceiling value of $1,667.78 and a performance period through November 16, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $42,641.11 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 per unit. The delivery order is part of a larger indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $10,674.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,294,526 units of the medication JANUMET XR 50-1,000 mg tablets. This contract is a child order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,072,292 units of the pharmaceutical product JANUMET XR 50-1,000 mg tablets in 180-count packages. The total ceiling value of the contract is $2,687.00 with a period of performance through March 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $6,462.38 firm-fixed-price contract is for the supply of 180 count bottles of the pharmaceutical product JANUMET XR 50-1,000 MG TABLET. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for a comprehensive range of medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $11,952.94 firm-fixed-price contract is for the supply of JANUMET XR 50-1,000 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,183.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide JANUMET XR 50-1,000 MG tablets in quantities of 180 per bottle. This delivery order is part of a larger indefinite delivery contract with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp as a single award, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $4,389.10. The contract is for the supply of 4,566,043,669 units of the prescription medication JANUMET XR 50-1,000 MG TABLET. This delivery order is part of a larger Indefinite Delivery Contract between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999 through December 2025, for a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,147.50 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563981933 JANUMET XR 50-1,000 MG TABLET 180S. This delivery order contract has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9GFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,745.04 to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide JANUMET XR 50-1,000 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the prime contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has a performance period through December 31, 2025 and does not have a set-aside designation.
Generated 7/1/24, 4:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/14/24 |